At United Theranostics, we proudly introduce the National Institute of Theranostics (NIT), a premier destination for advanced diagnostic and therapeutic solutions in nuclear medicine. This initiative represents our commitment to leadership in targeted radiopharmaceutical therapies and molecular imaging technologies that redefine cancer care.
The National Institute of Theranostics (NIT) is not just a title—it is the embodiment of our clinical and research excellence in treating complex cancers with precision, safety, and innovation.
Every service offered through the National Institute of Theranostics (NIT) is backed by our proprietary protocols, state-of-the-art radiopharmacy capabilities, and a commitment to compassionate, evidence-based care.
As the creators of the National Institute of Theranostics (NIT), United Theranostics leads the way in integrating radiopharmaceutical therapy into mainstream cancer care. Our team brings decades of combined experience in nuclear medicine, oncology, and radiopharmaceutical production to ensure the highest standards of safety and clinical efficacy.
When you see the National Institute of Theranostics (NIT) designation, you can trust you’re accessing an unmatched level of care.
We invite healthcare providers, referring oncologists, and patients to learn more about how our services can support cancer diagnosis and treatment.
👉 Schedule Your Consultation Now
Or call us directly at (575) 209-2800 to speak with our care team.
The National Institute of Theranostics (NIT) is operated exclusively by United Theranostics and represents our specialized program in radiopharmaceutical diagnostics and therapy.
Providing advanced radiopharmaceutical therapy for metastatic prostate cancer patients.
4391 E Lohman Ave. Suite A Las Cruces, NM 88011
© 2025 United Theranostics. All Rights Reserved.